Nurse Practitioner in Pennington, NJ Accepting Medicare

65 Nurse Practitioner nurses found. Showing 61 - 65

Debra Lynn Maude, CRNP Nurse Practitioner - Acute Care Medicare: Accepting Medicare Assignments Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4000

Theresa Core, Nurse Practitioner - Primary Care Medicare: Accepting Medicare Assignments Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4000

Betty Adankwah, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4000

Mrs. Rondella Thompson, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4000

Janine Santora, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2 Capital Way, Pennington, NJ 08534 Phone: 609-537-7300    Fax: 609-537-7301

News Archive

New cancer research model bridges health disparity gap

The Accelerated Community Oncology Research Network (ACORN), a national oncology clinical trial network, has announced that it is bridging the disparity gap in healthcare to underserved communities by enrolling more than double the national average of African Americans in cancer-related clinical trials.

Melody Transcatheter Pulmonary Valve brings new hope to congenital heart patients

Many adult congenital heart patients have undergone multiple heart surgeries by the time they reach their 20s. Each time surgeons operate on the heart, the risk of complications increases.

Study identifies epigenetic events critical to cancer cell survival

USC Norris Comprehensive Cancer Center research that identifies specific genes that have to be turned off in order for cancer cells to survive was named one of the top major advances in cancer research this year by the American Society of Clinical Oncology (ASCO).

Lilly announces CHMP positive opinion for ixekizumab for treatment of adults with plaque psoriasis

Eli Lilly and Company announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for ixekizumab for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union who are candidates for systemic therapy.

Read more Medical News

› Verified 5 days ago

• 1
• 2
• 3
• 4(current)